Friess Associates’s Insulet PODD Stock Holding History

Friess Associates’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$26K	–	103
2021 Q1	$26K	Buy	+100	New	+$26.8K	0.01%	92

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Friess Associates's PODD Position: Q2 2021 in Review

Friess Associates sold out of Insulet (PODD) in Q2 2021, closing a stake of 100 shares — an estimated $26K sold.

Friess Associates first reported a position in PODD in Q1 2021 and held it in 1 quarter. The position peaked at $26K in Q1 2021. 463 funds tracked by Wall St. Rank hold PODD as of Q2 2021.

Friess Associates reported no remaining Insulet position as of Q2 2021 after selling out during the quarter.
Friess Associates sold 100 Insulet shares in Q2 2021, an estimated $26K.
Friess Associates first reported a position in Insulet in Q1 2021 and held it in 1 quarter.
Friess Associates's Insulet position peaked at $26K in Q1 2021.
463 funds tracked by Wall St. Rank held Insulet as of Q2 2021.

Based on Friess Associates's 13F filing for Q2 2021, filed 11 Aug 2021.